JL

Jeremy Levin

Ceryvyn Therapeutics Limited | Non-Executive Chairman, Non-Executive Director
Dr Levin has served as the Chief Executive Officer of Ovid Therapeutics Inc., and since 2014, as Chairperson of the board of directors, of Ovid. From May 2012 to October 2013, He served as the President and Chief Executive Officer of Teva Pharmaceutical Industries Ltd., a publicly held pharmaceutical company. From September 2007 to December 2012, he held several roles at Bristol Myers Squibb Company, a publicly held pharmaceutical company, ultimately serving as the Senior Vice President of Strategy, Alliances and Transactions. He is also a member of Governance Committee.

Companies and Roles

Company
Title
Tenure
Since
OPT
OPT
Ceryvyn Therapeutics Limited
  • Non-Executive Chairman
  • Non-Executive Director
5yrs, 9mthOct 2020
CYV
CYV
Ceryvyn Therapeutics Limited
  • Non-Executive Chairman
  • Non-Executive Director
5yrs, 9mthOct 2020

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
CYV
CYV
Ceryvyn Therapeutics Limited
23/06/2613,393,937N/A53,000,000N/A
OPT
OPT
Ceryvyn Therapeutics Limited
23/06/2613,393,937N/A53,000,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
CYV
CYV
Ceryvyn Therapeutics Limited
23/06/26
Buy
13,390,000$0.014$188,799On-market trade
OPT
OPT
Ceryvyn Therapeutics Limited
23/06/26
Buy
13,390,000$0.014$188,799On-market trade
CYV
CYV
Ceryvyn Therapeutics Limited
19/06/26
Issued
48,000,000$0.014$672,000Issue of options
OPT
OPT
Ceryvyn Therapeutics Limited
19/06/26
Issued
48,000,000$0.014$672,000Issue of options
OPT
OPT
Ceryvyn Therapeutics Limited
17/12/24
Issued
2,000,000$0.635$1,270,000Issue of options